ENCINITAS, CA, Vasa Therapeutics announced the closing of a $6M series seed funding led by Orphinic Scientific SA.
Vasa Therapeutics announces the closing of a $6M series seed funding led by Orphinic Scientific SA with additional support from NuFund Venture Group and SeedFolio.
Vasa is a preclinical stage biopharmaceutical company developing novel therapies for cardiovascular aging.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
